一名患有器质性心境障碍的患者因冠状病毒病大流行引发惊恐障碍，使用伏硫西汀成功治愈。
Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine.
作者信息
Yoshimura Reiji, Okamoto Naomichi, Konishi Yuki, Ikenouchi Atsuko
机构信息
Department of Psychiatry, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 8078555, Japan.
出版信息
Case Rep Psychiatry. 2020 Nov 2;2020:8870014. doi: 10.1155/2020/8870014. eCollection 2020.
We present a case of panic disorder induced by the coronavirus disease (COVID-19) pandemic in a patient with an organic mood disorder. The patient was a 62-year-old woman with mild mood swings and reduced motivation and volition caused by a traumatic brain injury after a traffic accident. She was maintained on carbamazepine (600 mg/day). When the COVID-19 outbreak occurred in Japan, she developed concerns regarding the illness and complained of multiple episodes of panic attacks. Further, her depressive symptoms worsened. Thus, vortioxetine was added to the ongoing CBZ treatment. Four weeks after initiating vortioxetine treatment, the symptoms of panic disorder and depressive state were ameliorated. The present case suggests that vortioxetine augmentation can improve symptoms of depressive state and panic disorder induced by the COVID-19 pandemic.
我们报告一例患有器质性心境障碍的患者因冠状病毒病（COVID-19）大流行诱发惊恐障碍的病例。该患者为一名62岁女性，因交通事故导致创伤性脑损伤，出现轻度情绪波动，动机和意志减退。她一直服用卡马西平（600毫克/天）。当日本爆发COVID-19疫情时，她对该病产生担忧，并主诉多次惊恐发作。此外，她的抑郁症状加重。因此，在正在进行的卡马西平治疗基础上加用了伏硫西汀。伏硫西汀治疗开始四周后，惊恐障碍和抑郁状态的症状得到改善。本病例提示，加用伏硫西汀可改善COVID-19大流行诱发的抑郁状态和惊恐障碍症状。
Zotero 插件